Clinical Trials on Moderate Chronic Obstructive Pulmonary Disease in New Zealand
Total 5379 results
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPDNew Zealand
-
Waikato HospitalWaikato Hospital Research FundCompletedChronic Obstructive Pulmonary DiseaseNew Zealand
-
University of Auckland, New ZealandTerminatedSmoking Cessation | Chronic Obstructive Pulmonary DiseaseNew Zealand
-
Mylan Inc.Theravance BiopharmaCompleted
-
Canandaigua VA Medical CenterRecruitingChronic Obstructive Pulmonary Disease ModerateUnited States
-
University of OtagoHealth Research Council, New ZealandCompleted
-
Fisher and Paykel HealthcareMedical Research Institute of New Zealand; Alana HealthcareTerminatedChronic Obstructive Pulmonary Disease | COPDUnited States, New Zealand
-
Meridigen Biotech Co., Ltd.Active, not recruitingChronic Obstructive Pulmonary Disease ModerateTaiwan
-
GlaxoSmithKlineCompleted
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Denmark, France, Sweden, Thailand, Vietnam, Belgium, Brazil, Peru, Philippines, Turkey, Taiwan, Argentina, Australia, Israel, Poland, Ukraine, Slovenia, Serbia, Mexico, Bulgaria, Colombia, New Zealand, Chile, Norway, Croatia
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, New Zealand
-
Mundipharma Research LimitedCompletedChronic Obstructive Pulmonary DiseaseChina, Taiwan, Korea, Republic of, New Zealand, Australia
-
Convexity Scientific IncCOPD FoundationCompletedChronic Obstructive Pulmonary Disease | COPD | Chronic Obstructive Pulmonary Disease Moderate | Chronic Obstructive Pulmonary Disease SevereUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedStudy in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017Chronic Obstructive Pulmonary Disease (COPDUnited States, Australia, New Zealand
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
-
The George InstituteActive, not recruitingCardiovascular Diseases | Chronic Obstructive Pulmonary DiseaseAustralia, New Zealand
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)Spain, Germany, South Africa, Australia, Poland, New Zealand, Netherlands
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Chile, South Africa, New Zealand
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, United States, New Zealand
-
DeyCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand
-
Theravance BiopharmaGlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveThailand, New Zealand, United Kingdom
-
Arrowhead PharmaceuticalsRecruitingChronic Obstructive Pulmonary Disease | AsthmaKorea, Republic of, Australia, New Zealand, Poland, Thailand, Spain
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
Flinders UniversityCompletedChronic Obstructive Pulmonary Disease | DyspneaAustralia, New Zealand
-
EmphycorpCellular Sciences, inc.Completed
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingChronic Obstructive Pulmonary Disease (COPD)United States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand
-
AstraZenecaQuintiles, Inc.Completed
-
Turino, Gerard, M.D.National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Northwell HealthTerminatedChronic Obstructive Pulmonary DiseaseUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand, United Kingdom
-
Columbia UniversityNational Institute of Environmental Health Sciences (NIEHS)CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Optimum Patient CareRespiratory Effectiveness Group; Boehringer Ingelheim Pharmaceutical Company... and other collaboratorsUnknownChronic Obstructive Pulmonary Disease (13645005)United States
-
The George InstituteNational Health and Medical Research Council, AustraliaCompletedChronic Obstructive Pulmonary DiseaseAustralia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, Romania, Bulgaria, Germany, Netherlands, New Zealand
-
Pulmatrix Inc.The VA Western New York Healthcare System; Buffalo Institute For Medical ResearchCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease, COPDFrance, Poland, South Africa, Spain, United States, Canada, United Kingdom
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedEmphysema | HIV | Chronic Obstructive Pulmonary Disease (COPD)United States
-
Weill Medical College of Cornell UniversityTerminatedChronic Obstructive Pulmonary Disease | COPDUnited States
-
Weill Medical College of Cornell UniversityTerminatedSmoking | Chronic Obstructive Pulmonary Disease | COPDUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseAustralia, New Zealand
-
Beth Israel Medical CenterJohnson & JohnsonCompletedPulmonary DiseasesUnited States
-
MediciNovaCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
DeyCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
University of RochesterCompletedChronic Obstructive Pulmonary DiseaseUnited States